Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Exelixis
Related studies linked through entity extraction aliases.
A Safety Study of XL019 in Adults With Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE1
A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Study of XL418 in Adults With Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
Study of XL281 in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of XL820 Given Orally Daily to Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of XL820 in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1